A Comprehensive Guide to Biomarkers in Clinical Trials
Biomarkers are no longer optional in modern drug development; they are central to how sponsors design, execute, and interpret clinical trials. Whether identifying the right patient population, confirming early biological activity, or guiding dose selection, biomarkers help teams make faster, evidence-based decisions. For sponsors running precision medicine or targeted therapy programs, biomarkers reduce uncertainty and […]